Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Arvinas Inc before investing.

In this article, we go over a few key elements for understanding Arvinas Inc’s stock price such as:

• Arvinas Inc’s current stock price and volume
• Why Arvinas Inc’s stock price changed recently
• Upgrades and downgrades for ARVN from analysts
• ARVN’s stock price momentum as measured by its relative strength

About Arvinas Inc (ARVN)

Before we jump into Arvinas Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Arvinas, Inc. is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The Company uses its PROTAC Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. It has four investigational clinical-stage programs: vepdegestrant (ARV-471) for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-766 and bavdegalutamide for the treatment of men with metastatic castration-resistant prostate cancer, and ARV-102 for the treatment of patients with neurodegenerative disorders. Its product candidate, ARV-393, is designed to target the B-cell lymphoma 6, or BCL6 protein.

Want to learn more about Arvinas Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Arvinas Inc.

Arvinas Inc’s Stock Price as of Market Close

As of May 21, 2024, 4:00 PM, CST, Arvinas Inc’s stock price was $34.65.

Arvinas Inc is up 4.18% from its previous closing price of $33.26.

During the last market session, Arvinas Inc’s stock traded between $31.86 and $33.61. Currently, there are 71.70 million shares of Arvinas Inc stock available for purchase.

Unfortunately, Arvinas Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Arvinas Inc Stock Price History

Arvinas Inc’s (ARVN) price is currently up 9.07% so far this month.

During the month of May, Arvinas Inc’s stock price has reached a high of $34.86 and a low of $31.24.

Over the last year, Arvinas Inc has hit prices as high as $53.08 and as low as $13.57. Year to date, Arvinas Inc’s stock is up 1.29%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Arvinas Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 20, 2024, there were 2 analysts who downgraded Arvinas Inc’s stock and 12 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Arvinas Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Arvinas Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Arvinas Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Arvinas Inc (ARVN) by visiting AAII Stock Evaluator.

Relative Price Strength of Arvinas Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 20, 2024, Arvinas Inc has a weighted four-quarter relative price strength of 5.66%, which translates to a Momentum Score of 80 and is considered to be Strong.

Want to learn more about how Arvinas Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Arvinas Inc Stock Price: Bottom Line

As of May 21, 2024, Arvinas Inc’s stock price is $34.65, which is up 4.18% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Arvinas Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.